Literature DB >> 21480829

Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia.

R M Williamson1, S Mallaiah, P Barclay.   

Abstract

BACKGROUND: Many anaesthetists use rocuronium in place of suxamethonium for rapid sequence induction (RSI). This is less common in obstetric anaesthesia as the duration of action of an effective dose of rocuronium exceeds most obstetric procedures. Sugammadex offers the possibility of rapidly reversing profound rocuronium neuromuscular blockade at the end of surgery. We aimed to determine whether rocuronium 1.2 mg/kg used for RSI in the obstetric population would provide good intubating conditions at 60 s and would be effectively reversed by sugammadex at the end of surgery.
METHODS: We present a prospective series of 18 patients who received rocuronium 1.2 mg/kg at induction of anaesthesia, monitored with a train-of-four ratio (TOF)-Watch SX(®) , and reversed using sugammadex 4 mg/kg.
RESULTS: The mean (95% CI) onset time of rocuronium was 71 (56-86) s, and the mean (95% CI) time to recovery of the TOF to ≥90%, after the administration of sugammadex 4 mg/kg at the end of surgery, was 86 (69-104) s.
CONCLUSION: Rocuronium 1.2 mg/kg reversed by sugammadex appears to be effective in the obstetric population.
© 2011 The Authors. Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21480829     DOI: 10.1111/j.1399-6576.2011.02431.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

Review 1.  Rethinking general anesthesia for cesarean section.

Authors:  Hiroyiki Sumikura; Hidetomo Niwa; Masaki Sato; Tatsuo Nakamoto; Takashi Asai; Satoshi Hagihira
Journal:  J Anesth       Date:  2015-11-19       Impact factor: 2.078

2.  [Modified rapid sequence induction for Caesarian sections : case series on the use of rocuronium and sugammadex].

Authors:  D Nauheimer; C Kollath; G Geldner
Journal:  Anaesthesist       Date:  2012-08       Impact factor: 1.041

3.  Sugammadex: An Update.

Authors:  Tiberiu Ezri; Mona Boaz; Alexander Sherman; Marwan Armaly; Yitzhak Berlovitz
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09

Review 4.  Sugammadex: A Review of Neuromuscular Blockade Reversal.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

5.  The Effects of Sugammadex on Progesterone Levels in Pregnant Rats.

Authors:  Tayfun Et; Ahmet Topal; Atilla Erol; Aybars Tavlan; Alper Kılıçaslan; Sema Tuncer Uzun
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

6.  Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery.

Authors:  Abdulhamid Alsaeed; Fahad Bamehriz; Sharaf Eldin; Tareq Alzahrani; Abdullah Alharbi; Abdelazeem Eldawlatly
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

7.  Recovery of residual curarization after red blood cell transfusion.

Authors:  Veit-Simon Eckle; Eckhard Schmid; Tanja Fehm; Christian Grasshoff
Journal:  Med Sci Monit       Date:  2012-11

Review 8.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.